Send to

Choose Destination
Crit Rev Eukaryot Gene Expr. 2015;25(4):335-47.

TGF-β in Inflammatory Bowel Diseases: A Tale of the Janus-Like Cytokine.

Author information

Department of Gastroenterology, Xin Hua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Department of Gastroenterology, Shanghai Jiao Tong University, School of Medicine, Xin Hua Hospital, Shanghai, China;Shanghai Institute of Pediatric Research, Shanghai, China;Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition.


Transforming growth factor-β (TGF-β) is a pleiotropic cytokine that controls an immense number of cellular responses and plays a prominent role in maintaining homeostasis of most human organs. In the intestine, the TGF-β is involved in mucosal defense, immune tolerance, inhibition of acute inflammation, promoting the wound-healing process, and suppressing tumor initiation. However, TGF-β exhibits Janus-like features under certain physiologic conditions and chronic inflammation (e.g., inflammatory bowel diseases [IBDs]). Excessive TGF-β in IBDs favors chronic inflammation, incurs pathologic remolding, and facilitates the progression of colitis-associated inflammation (CAC). Considering the increasingly crucial roles of TGF-Β in the development of IBDs, we overview its pathways and multifaceted effects at the steady-state and IBD conditions of the gut, respectively. In addition, we present potential therapeutic strategies aimed at restoring normal TGF-β signaling in IBDs.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for BegellHouse Publisher, Inc.
Loading ...
Support Center